Concepedia

Konrad Aumann

KA

31

Publications

1.5K

Citations

21

H-Index

2010

Active since

Affiliations

University Medical Center Freiburg(Current)

University of Freiburg

German Cancer Research Center

Medizinische Hochschule Hannover

Deutschen Konsortium für Translationale Krebsforschung

Konrad Aumann is an author at University Medical Center Freiburg specializing in medicine, pathology, and cell biology.

ORCID

Top concepts

Publications per year

2010–2024

31

Publications

31

Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma

Christine Dierks, Jochen Seufert, Konrad Aumann et al. · Thyroid · 2021 · 225 citations · Full text

Oncogenic JAK2 <sup>V617F</sup> causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms

Alessandro Prestipino, Alica Joana Emhardt, Konrad Aumann et al. · Science Translational Medicine · 2018 · 218 citations · Full text

Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia

Nadia El Khawanky, Amy Hughes, Wenbo Yu et al. · Nature Communications · 2021 · 99 citations · Full text

MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors

Dominik Marschner, Martina Falk, Nóra Rebeka Jávorniczky et al. · JCI Insight · 2020 · 81 citations · Full text

MPN patients harbor recurrent truncating mutations in transcription factor NF-E2

Jonas S. Jutzi, Ruzhica Bogeska, Gorica Nikoloski et al. · The Journal of Experimental Medicine · 2013 · 77 citations · Full text

, , +15

Rows per page

1–5 of 31